Fábio Cassola, Nedy Ramírez, Camila Delarmelina, Marta Cristina Teixeira Duarte
{"title":"In vitro determination of the susceptibility of Malassezia furfur biofilm to different commercially used antimicrobials","authors":"Fábio Cassola, Nedy Ramírez, Camila Delarmelina, Marta Cristina Teixeira Duarte","doi":"10.1111/apm.13419","DOIUrl":null,"url":null,"abstract":"<i>Malassezia furfur</i> is a yeast known as the etiological agent of seborrheic dermatitis. We evaluated the action of five different antimicrobials (amphotericin B, chloramphenicol, ketoconazole, fluconazole, and nystatin) on inhibiting biofilm formation and removing biofilm already formed by <i>M. furfur</i>. The assays were carried out using the microdilution method, and scanning electron microscopy images were used to analyze the biofilm structure. According to the results obtained, the percentage of inhibition was higher for chloramphenicol, followed by ketoconazole, nystatin, and amphotericin B. Regarding the eradication of the biofilm formed, the highest percentage was chloramphenicol, followed by ketoconazole and nystatin. Amphotericin B did not affect biofilm eradication, whereas fluconazole did not cause significant changes inhibiting or removing <i>M. furfur</i> biofilm. Therefore, except for fluconazole, all evaluated antimicrobials had inhibiting effects on the biofilm of <i>M. furfur</i>, either in its formation and/or eradication. Although the results achieved with chloramphenicol have been highlighted, further <i>in vitro</i> and <i>in vivo</i> studies are still needed in order to include this antimicrobial in the therapy of seborrheic dermatitis due to its toxicity, especially to the bone marrow.","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"292 1","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Apmis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/apm.13419","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Malassezia furfur is a yeast known as the etiological agent of seborrheic dermatitis. We evaluated the action of five different antimicrobials (amphotericin B, chloramphenicol, ketoconazole, fluconazole, and nystatin) on inhibiting biofilm formation and removing biofilm already formed by M. furfur. The assays were carried out using the microdilution method, and scanning electron microscopy images were used to analyze the biofilm structure. According to the results obtained, the percentage of inhibition was higher for chloramphenicol, followed by ketoconazole, nystatin, and amphotericin B. Regarding the eradication of the biofilm formed, the highest percentage was chloramphenicol, followed by ketoconazole and nystatin. Amphotericin B did not affect biofilm eradication, whereas fluconazole did not cause significant changes inhibiting or removing M. furfur biofilm. Therefore, except for fluconazole, all evaluated antimicrobials had inhibiting effects on the biofilm of M. furfur, either in its formation and/or eradication. Although the results achieved with chloramphenicol have been highlighted, further in vitro and in vivo studies are still needed in order to include this antimicrobial in the therapy of seborrheic dermatitis due to its toxicity, especially to the bone marrow.
糠秕马拉色菌是一种酵母菌,是脂溢性皮炎的病原体。我们评估了五种不同抗菌药物(两性霉素 B、氯霉素、酮康唑、氟康唑和硝司他丁)对抑制糠秕马拉色菌生物膜形成和清除糠秕马拉色菌已形成的生物膜的作用。实验采用微稀释法进行,并使用扫描电子显微镜图像分析生物膜结构。结果表明,氯霉素的抑制率较高,其次是酮康唑、硝霉素和两性霉素 B。两性霉素 B 不影响生物膜的根除,而氟康唑在抑制或清除糠秕孢子菌生物膜方面没有显著变化。因此,除氟康唑外,所有评估的抗菌药物对糠秕孢子菌生物膜的形成和/或根除都有抑制作用。虽然氯霉素取得的效果突出,但由于其毒性,尤其是对骨髓的毒性,仍需进一步进行体外和体内研究,才能将这种抗菌剂纳入脂溢性皮炎的治疗中。
期刊介绍:
APMIS, formerly Acta Pathologica, Microbiologica et Immunologica Scandinavica, has been published since 1924 by the Scandinavian Societies for Medical Microbiology and Pathology as a non-profit-making scientific journal.